Some older studies examined combinations of weaker GLP-1 drugs with DPP-4 inhibitors, showing modest additional glucose lowering compared to either drug alone, but the incremental benefit did not justify the added complexity and cost for most patients
Designed for support, not to interact with GLP-1 processes
It helps signal fullness, supports insulin response, slows stomach emptying, and communicates with appetite centers in the brain
WATER, ETHYLHEXYL METHOXYCINNAMATE, BUTYLENE GLYCOL, ETHYLHEXYL SALICYLATE, OCTOCRYLENE, BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE, BUTYL METHOXYDIBENZOYLMETHANE, DIPROPYLENE GLYCOL, NIACINAMIDE, SQUALANE, C14-22 ALCOHOLS, 1,2-HEXANEDIOL, POLYGLYCERYL-2 STEARATE, PROPANEDIOL, HYDROXYACETOPHENONE, GLYCERYL STEARATE, STEARYL ALCOHOL, C12-20 ALKYL GLUCOSIDE, TROMETHAMINE, CENTELLA ASIATICA EXTRACT, CARBOMER, MELALEUCA ALTERNIFOLIA (TEA TREE) EXTRACT, HIPPOPHAE RHAMNOIDES FRUIT EXTRACT, VITIS VINIFERA (GRAPE) FRUIT EXTRACT, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, UNCARIA SINENSIS EXTRACT, GLYCERIN, ADENOSINE, DISODIUM EDTA, ORYZA SATIVA (RICE) BRAN EXTRACT, HYDROGENATED PHOSPHATIDYLCHOLINE, CAPRYLIC/CAPRIC TRIGLYCERIDE, SODIUM HYALURONATE, GLUCOSE, HYDROLYZED COLLAGEN, SUCROSE STEARATE, GLUTATHIONE, CYCLODEXTRIN, CETEARYL ALCOHOL, CAPRYLYL GLYCOL, BETA-GLUCAN, CAPRYLHYDROXAMIC ACID, ETHYLHEXYLGLYCERIN, ASIATIC ACID, ASIATICOSIDE, MADECASSIC ACID, MADECASSOSIDE, TROPOLONE, HYALURONIC ACID, POTASSIUM HYALURONATE *** Ingredients are subject to change at the manufacturer's discretion
